1. A Review of Perspectives on the Use of Randomization in Phase II Oncology Trials. (20th June 2019) Authors: Grayling, Michael J; Dimairo, Munyaradzi; Mander, Adrian P; Jaki, Thomas F Journal: Journal of the National Cancer Institute Issue: Volume 111:Number 12(2019) Page Start: 1255 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Designing and evaluating dose-escalation studies made easy: The MoDEsT web app. (April 2020) Authors: Pallmann, Philip; Wan, Fang; Mander, Adrian P; Wheeler, Graham M; Yap, Christina; Clive, Sally; Hampson, Lisa V; Jaki, Thomas Journal: Clinical trials Issue: Volume 17:Number 2(2020) Page Start: 147 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Extended and standard duration weight-loss programme referrals for adults in primary care (WRAP): a randomised controlled trial. Issue 10085 (3rd June 2017) Authors: Ahern, Amy L; Wheeler, Graham M; Aveyard, Paul; Boyland, Emma J; Halford, Jason C G; Mander, Adrian P; Woolston, Jennifer; Thomson, Ann M; Tsiountsioura, Melina; Cole, Darren; Mead, Bethan R; Irvine, Lisa; Turner, David; Suhrcke, Marc; Pimpin, Laura; Retat, Lise; Jaccard, Abbygail; Webber, Laura;... Journal: Lancet Issue: Volume 389:Issue 10085(2017) Page Start: 2214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Group sequential designs for stepped-wedge cluster randomised trials. (October 2017) Authors: Grayling, Michael J; Wason, James MS; Mander, Adrian P Journal: Clinical trials Issue: Volume 14:Number 5(2017) Page Start: 507 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study. Issue 12 (8th December 2015) Authors: Truman, Lucy A; Pekalski, Marcin L; Kareclas, Paula; Evangelou, Marina; Walker, Neil M; Howlett, James; Mander, Adrian P; Kennet, Jane; Wicker, Linda S; Bond, Simon; Todd, John A; Waldron-Lynch, Frank Journal: BMJ open Issue: Volume 5:Issue 12(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design. (17th June 2020) Authors: Dimairo, Munyaradzi; Pallmann, Philip; Wason, James; Todd, Susan; Jaki, Thomas; Julious, Steven A; Mander, Adrian P; Weir, Christopher J; Koenig, Franz; Walton, Marc K; Nicholl, Jon P; Coates, Elizabeth; Biggs, Katie; Hamasaki, Toshimitsu; Proschan, Michael A; Scott, John A; Ando, Yuki; Hind, Dan... Journal: BMJ Issue: Volume 369(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. The choice of test in phase II cancer trials assessing continuous tumour shrinkage when complete responses are expected. (December 2015) Authors: Wason, James MS; Mander, Adrian P Journal: Statistical methods in medical research Issue: Volume 24:Number 6(2015:Dec.) Page Start: 909 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗